Document Detail

Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia/reperfusion injury.
MedLine Citation:
PMID:  20723957     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: High-mobility group box 1 (HMGB1) is a mediator of inflammation with dose-dependent effects. In the setting of regional myocardial infarction, a high-dose HMGB1 treatment decreases myocardial function, whereas low-dose HMGB1 improves function; however, it is unknown what role HMGB1 has in the setting of global ischemia/reperfusion (I/R) injury. We hypothesized that a low-dose HMGB1 treatment would improve myocardial functional recovery and decrease infarct size after global I/R injury in association with increased levels of cardioprotective paracrine factors and decreased inflammation.
METHODS: Adult rat hearts were isolated and perfused using the Langendorff method and were subjected to global I/R and treatment with either the vehicle, 200-ng HMGB1, or 1-μg HMGB1. The treatment was administered during 1 min at the start of reperfusion, and myocardial function was measured for 60 min of reperfusion. At the end of reperfusion, the hearts were sectioned and incubated in triphenyltetrazolium chloride to assess myocardial infarct size or homogenized to measure levels of inflammatory cytokines and growth factors.
RESULTS: Postischemic treatment with 200-ng HMGB1 significantly improved myocardial functional recovery after global I/R in association with decreased infarct size and decreased interleukin-1 (IL-1), IL-6, IL-10, and vascular endothelial growth factor (VEGF) levels. In addition, 1-μg HMGB1 decreased myocardial inflammation but did not result in subsequent improvement in functional recovery.
CONCLUSION: In the setting of global I/R, 200-ng postischemic HMGB1 treatment improves myocardial function and decreases infarct size in association with suppressed myocardial inflammation. These results suggest a potential role for exogenous HMGB1therapy in the acute postischemic period.
Aaron M Abarbanell; Jacob A Hartley; Jeremy L Herrmann; Brent R Weil; Yue Wang; Mariuxi C Manukyan; Jeffrey A Poynter; Daniel R Meldrum
Related Documents :
12546727 - Protective effects of xanthones against myocardial ischemia-reperfusion injury in rats.
10881827 - Free hemoglobin impairs cardiac function in neonatal rabbit hearts.
3995717 - Echocardiographically detected dyskinesis, myocardial infarct size, and coronary risk r...
16603707 - Oxygen reperfusion is limited in the postischemic hypertrophic myocardium.
14529587 - Possible involvement of apoptotic death of myocytes in left ventricular remodeling afte...
17286297 - Evaluation of the general practice research database congenital heart defects prevalenc...
Publication Detail:
Type:  Journal Article     Date:  2010-08-19
Journal Detail:
Title:  Surgery     Volume:  149     ISSN:  1532-7361     ISO Abbreviation:  Surgery     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417347     Medline TA:  Surgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  329-35     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 Mosby, Inc. All rights reserved.
Department of Surgery, Indianapolis, IN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Postoperative parathyroid hormone testing decreases symptomatic hypocalcemia and associated emergenc...
Next Document:  Two-stage brachial-basilic transposition fistula provides superior patency rates for dialysis access...